On the CPhI China in Shanghai, Ralf Sibbing will introduce Chinese pharmaceutical companies to the particulars of the medicinal product market in the European Union and how to successfully obtain EU registrations for their products (“欧盟药品市场及上市许可成功因素”). In addition, Diapharm’s general manager will discuss foreseeable effects of the Brexit procedure for companies holding drug marketing authorisations in the EU and in the UK. CPhI China, which takes place in the Shanghai New International Expo Centre, is among the most important pharmaceutical trade fairs globally, attracting more than 40.000 professionals from 120 countries.
